Abstract
Introduction
The discovery of the lin-4 small non-coding RNA in C. elegans in 1993 [1] [2] . miRNAs exert their regulatory effect post-transcriptionally by binding the 3Ј-UTR of their target mRNA and inhibiting target gene translation to protein [3] .
initiated research focused on the cellular function of microRNAs (miRNAs). Since then, the ~21-22-nt-long noncoding RNAs have been shown to have a central role in gene expression regulation and have been implicated in many pathological conditions
Vertebrate miRNAs target theoretically around 200 mRNA transcripts each and a single target can be co-ordinately regulated by more than one miRNA [4] . Depending on whether miRNAs target oncogenes or tumour suppressor genes, they act as tumour suppressors or oncogenes, respectively [5] . Numerous studies, using different profiling approaches, have demonstrated that miRNA expression is deregulated in various human cancers [6] [7] [8] [9] .
Primary miRNA and pre-miRNA are processed to the mature miRNA by two RNase III endonucleases -Drosha in the nucleus and Dicer in the cytoplasm [10] . The mature miRNA is then loaded to the miRNA-induced silencing complex (miRISC) . The main components of the miRISC are the Argonaute (Ago) family of proteins, Ago 1-4 [3] . The miRISC is required for the action of the mature miRNA on the target mRNA. Changes in the machinery proteins affect miRNA biogenesis and action.
Ovarian [11] .
carcinoma (OC), the most lethal gynaecological cancer, ranks fifth in cancer related-deaths among women and is frequently referred to as the 'silent killer', with the majority of patients diagnosed with advanced-stage (FIGO stages III-IV) disease
miRNA expression in OC is an area of active ongoing research. Several studies have demonstrated differences in the miRNA profile of OC and benign ovarian surface epithelium [12] [13] [14] [15] [16] [17] [18] [19] , as well as in Dicer expression [20, 21] . miRNA levels in clinical OC and OC cell lines have been shown to be inversely correlated to those of target genes they regulate, including PTEN [14] , Bmi-1 [22] and inhibitor of kappa light polypeptide gene enchancer in B-cells, kinase beta (IKK-␤) [23] . Association between miRNA levels and clinicopathological parameters, response to chemotherapy and/or survival have been reported by several groups, with both poor and better patient outcome reported for different miRNAs [14, [24] [25] [26] [27] [28] . Correlation between Dicer and Drosha levels and survival has been reported by some investigators [29, 30] , although others found no such role for these molecules [15, 20] . Different miRNA profile was recently reported for primary OC and recurrent disease [31] . Finally, no somatic mutations were found in 10 cancer-associated miRNA genes in clinical OC [32] . Figure 1B .
Material and methods

Patients and tumour specimens
qRT-PCR of selected miRNAs in set 2
An independent set of samples comprised 15 primary carcinomas and 30 effusion specimens was studied for the expression of selected miRNAs and housekeeping genes using qRT-PCR (Fig. 2) [35] [36] [37] , as well as in OC [19, 28] 
ZEB1
ZEB1 is a predicted and validated target of hsa-miR-200c [35] . The involvement of both molecules in EMT is established [36, 37] . As we were unable to detect ZEB1 using commercially available antibodies, we analysed ZEB1 mRNA levels by qRT-PCR. ZEB1 was more highly expressed in primary carcinomas compared to effusions (P ϭ 0.028). In contrast, as detailed above, hsa-miR-200c was more highly expressed in effusions compared to primary OC
Fig. 1 miRNA expression in primary OC versus effusions. (A) Volcano plot representation of the 13 array results. (B) Venn diagram representation of the 13 array results. The three groups shown are miRNAs overexpressed in primary OC (n ϭ 6), miRNAs overexpressed in effusions (n ϭ 12) and miRNAs that are highly expressed at both anatomic sites (n ϭ 16).
( Fig. 3A) . mRNA levels of E-cadherin, which is negatively regulated by ZEB1, were similarly higher in effusions compared to primary carcinomas (P ϭ 0.004). [39, 40] . Figure 3B . [41] . PTEN is a tumour suppressor gene that is frequently mutated in cancer [42] . (Fig. 3C) . Fig. 4B ). [43] . Organ-specific miRNA expression profiles were described [44] , as well as miRNAs that are deregulated in three or more of six different solid cancer types studied by Volinia et al. [8] . Rosenfeld [15] , as well as in serous OC compared to normal tissue [17] . miR-214 expression was shown to be repressed in OC compared to benign cells by Nam et al. [17] , whereas opposite results were reported by Yang et al. [14] . Our findings show that miR-125b, miR-145 and miR-214 are repressed in effusions compared to primary OC, suggesting a role in the inhibition of tumour progression. Alternatively, this difference may be due to the unique microenvironment of effusions, as previously discussed [33] .
c-Myc c-Myc is a well-defined oncogene, overexpressed in a variety of malignancies. It is a key transcription factor in many cellular processes such as proliferation, apoptosis and cell adhesion
Using prediction algorithms, we identified c-Myc as a putative target of hsa-miR-200c. In agreement with this, Western blot analysis demonstrated that c-Myc protein is expressed at higher levels in primary carcinomas compared to effusions (P Ͻ 0.001). This inverse relation between the miRNA and its predicted target is shown in
PAK1 and PTEN PAK1 regulates cell motility and morphology
Both genes are predicted targets of hsa-miR-222. We analysed the expression of the PAK1 and PTEN proteins by Western blot, and found that both proteins are more highly expressed in primary carcinomas compared to effusions (P ϭ 0.092 and P Ͻ 0.001, respectively), in agreement with the higher hsa-miR-222 expression in effusions
The miRNA processing machinery in OC progression
Immunohistochemistry analysis showed Ago1 and Dicer expression in 27/27 and 21/27 effusions, respectively (Fig. 4C). In primary carcinomas, Ago1 and Dicer were expressed in 23/25 and 24/25 tumours, respectively, whereas both proteins were detected in 34/39 solid metastases each (Fig. 4C). In contrast to the Western blotting results, this analysis failed to show any significant differences between the three anatomic sites for Ago1 (P ϭ 0.644) or Dicer (P ϭ 0.077). A two-tier analysis of primary carcinomas and effusions showed comparable results for Ago1 (P ϭ 0.451), whereas Dicer expression was higher in primary carcinomas (P ϭ 0.03).
Discussion
Gene expression profiling of cancers was postulated to identify molecular signatures associated with poor prognosis. Recently, it was reported that approximately 50% of all annotated human miRNAs are located in areas of the genome associated with cancer
miR-182 was reported to be elevated in tumour cell lines [15] and in advanced-stage OC [18] compared to normal tissue, and the region containing this miR was concordantly found to be amplified in OC [15] . miR-200c was found to be elevated in tumour cell lines [12] , serous OC [17] and advanced-stage OC [18] [46] . miR-210 [18] , miR-222 [12, 15] and let 7f [16] [51, 52] . Data regarding the clinical role of c-Myc status in primary OC have predominantly been negative. c-Myc mRNA expression was associated better response to chemotherapy and was an independent prognostic factor for overall survival in one study [53] , whereas c-Myc gene amplification or mRNA expression was not associated with any clinicopathological parameters, including survival, in three other studies [54] [55] [56] . Irrespective of the clinical relevance of c-Myc in OC, a recent study [57] [29] . Comparable data for Dicer were recently published by Faggad et al. [30] , although Flavin et al. found 
ZEB1 expression is higher in primary OC compared to effusions, whereas the opposite is true for miR-200c (Y-axis shows mean rank; *P Ͻ 0.05 for both). (B) Western blot for c-Myc, predicted target of miR-200c. c-Myc expression is higher in primary OC compared to effusions, whereas the opposite is true for miR-200c (Y-axis shows mean rank; P Ͻ 0.05 for both). A representative blot of five solid primary OC (S) and six effusions (E) is shown. (C) Western blot for PAK1 and PTEN, predicted targets of miR-222. Expression of both proteins is higher in primary OC compared to effusions (Y-axis shows mean rank; *P Ͻ 0.05), whereas the opposite is true for miR-222. A representative blot of five solid primary OC (S) and six effusions (E) is shown for PTEN, with the same specimens as for c-Myc. C: controls (left: solid tumour tested in a pilot study; right: MCF-7 breast carcinoma). For PAK1, five solid primary OC (S) and seven effusions (E) are shown. C: OVCAR-8 cell line. miR-210 expression is stimulated under hypoxic conditions and regulated by HIF signalling, and this miR is often deleted in OC
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